Benjamin P. Saylor
Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.
Clinicians say active surveillance is effective but rarely recommend it
The majority of urologists and radiation oncologists feel active surveillance is an effective and underused modality for managing low-risk prostate cancer; however, few of these specialists would recommend this strategy to patients, according to recent survey results.
Positive data on T products follow blood clot warning
Testosterone replacement therapy is in the news again, for reasons both good and bad.
June 2014 New Urology Products and Services
New products and services from TERUMO Medical Corp., TOLMAR Pharmaceuticals, Spry Publishing, and Beckman Coulter Diagnostics.
FDA OKs low T nasal gel, male incontinence device
The FDA has approved a nasal gel for men with hypogonadism and has granted clearance to a treatment for urinary incontinence in men. Separately, two drug makers are approaching the agency about regulatory approval for an over-the-counter version of a phosphodiesterase-type-5 inhibitor.
Phase III enzalutamide data published in NEJM
Phase III enzalutamide data published in NEJM
Results from the phase III PREVAIL trial of the oral androgen receptor inhibitor enzalutamide (XTANDI) have been published online in the New England Journal of Medicine (June 1, 2014).
June 2014 Urology Product Preview
Drugs in the pipeline from Astellas Pharma, Medivation, TesoRx, Strategic Science and Technologies, Cubist Pharmaceuticals, and SCA.
URS shows fewer repeat treatments than SWL
When compared with shock wave lithotripsy, ureteroscopy is associated with fewer repeat treatments, according to a recent study from Duke University.
Dr. Holden joins UCLA urology faculty
Stuart Holden, MD, has joined the UCLA faculty as a health sciences clinical professor in urology at the David Geffen School of Medicine. He was also appointed associate director of the UCLA Institute of Urologic Oncology, according to a UCLA press release.
Seat belts, airbags reduce renal injury, nephrectomy rates
Drivers or passengers involved in motor vehicle collisions have reduced rates of high-grade renal injury and nephrectomy when wearing protective devices, according to research presented at an AUA press briefing on Friday.
Effects of PDE-5 inhibitors, active surveillance among localized prostate cancer topics
Studies examining the post-prostatectomy effects of phosphodiesterase type-5 inhibitors and those discussing active surveillance are among the key papers in localized prostate cancer to be presented at this year's AUA annual meeting, according to Leonard G. Gomella, MD.


View Results